Resources
Explore how healthcare organizations, researchers, and life sciences partners from our global community use TriNetX to turn real-world patient data into evidence that drives progress.
The most important questions aren’t about the AI. They’re about the data beneath it, the scientific rigor behind it, the integration architecture around it, and the outcomes it has produced.
The era of the blockbuster drug and one-size-fits-all medicine is ending. What’s replacing it demands a fundamentally different approach to finding the right patients before a trial begins.
In this session, TriNetX and Parexel share a modern feasibility workflow designed for clinical operations teams, including non-medical users empowered through natural language and AI translation.
IBD involves a chronically inflamed gastrointestinal (GI) tract, and the GI side effect profile of GLP-1 receptor agonists raised legitimate questions about tolerability and disease exacerbation in these patients.
Upcoming Webinar
From Protocol Draft to Confident Feasibility: Democratizing Study Design with AI
Tuesday, September 15 | 10am ET
Join TriNetX and Parexel to explore how AI and real-world data are transforming clinical feasibility workflows.
Join a global community of innovators. Discover how to turn real-world data into groundbreaking clinical insights.
Meet TriNetX at Events
Bridge the gap between raw data and patient care. Meet the team at flagship healthcare conferences across the globe, and learn how to leverage the TriNetX ecosystem to streamline trial timelines, improve site collaboration, and publish research that changes lives.
Not sure where to start?
Find the right solution for your organization
Take the Real-World Impact Assessment. Answer a few questions to see how TriNetX can drive impact across your clinical and commercial goals.
